Co-Authors
This is a "connection" page, showing publications co-authored by Michelle Murti and Jonathan Gubbay.
Connection Strength
1.486
-
Impact of coronavirus disease 2019 (COVID-19) pre-test probability on positive predictive value of high cycle threshold severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcription polymerase chain reaction (RT-PCR) test results. Infect Control Hosp Epidemiol. 2021 Aug 09; 1-5.
Score: 0.240
-
CMAJ. 2021 07 19; 193(28):E1098-E1106.
Score: 0.239
-
Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic. PLoS One. 2021; 16(7):e0253941.
Score: 0.239
-
Investigation of a severe SARS-CoV-2 outbreak in a long-term care home early in the pandemic. CMAJ. 2021 05 10; 193(19):E681-E688.
Score: 0.236
-
Surveillance of persons-who tested negative for COVID-19 in Ontario, January 22-February 22, 2020. Can Commun Dis Rep. 2020 May 07; 46(5):150-154.
Score: 0.220
-
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ?possible cohort effect following the 2009 influenza pandemic. Euro Surveill. 2019 Apr; 24(15).
Score: 0.204
-
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017. Clin Infect Dis. 2020 11 19; 71(16):2285-2288.
Score: 0.057
-
Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Euro Surveill. 2019 Jan; 24(4).
Score: 0.050